Two PM(NOC) Actions Dismissed After Common Trial on Validity of Treatment Regimen Patent
Update: Expanded Federal Funding for Research and Innovation
Federal Court issues first decision on patent term restoration – Minister’s decision denying certificate of supplementary protection (CSP) is unreasonable
Health Canada Provides Guidance on Regulation of Software as a Medical Device (SaMD)
Federal Court reinstates damages decision concerning prejudgment interest
Competition Bureau issues statement regarding off-label use of vaccines
Competition Bureau publishes Final IP Enforcement Guidelines
FCA Confirms Entirety of Inventors’ Conduct is Relevant in Obviousness Analysis and Upholds Inventiveness of Crystal Form Patent
FCA Confirms that Non-Infringing Alternative Must be Legal and Objectively Economically Viable
Blogs
Firm/Org